Institutional investors purchased a net $952.7 thousand shares of ILMN during the quarter ended June 2016 and now own 98.54% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 1.9 Million shares of Illumina Inc
SANDS CAPITAL MANAGEMENT LLC Bought 1.0 Million shares of Illumina Inc
T. ROWE PRICE ASSOCIATES, INC. Bought 1.0 Million shares of Illumina Inc